Sonnet BioTherapeutics Holdings, Inc. (SONN) earnings
SONN earnings moved a median of +1.27% by the close. Quarterly and annual SONN reports and results, each read against the price at its own news timestamp. Back to the SONN overview →
13 measured SONN earnings events.
Where these SONN earnings landedvs 11 measured SONN earnings reactions
| Middle 50% of SONN earnings reactions | -2.60% to +2.65% |
|---|---|
| Median reaction (to close) | +1.27% |
| Measured reactions | 11 |
Point-in-time · zero look-ahead
Half of the 11 SONN earnings events with a measured close landed between -2.60% and +2.65%; 55% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Hyperliquid Strategies For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Hyperliquid Strategies For: Dec 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Sonnet BioTherapeutics For: Jun 30 | SEC filing · Form 10-Q | +9.85% | +7.43% | |
| Form 10-Q Sonnet BioTherapeutics For: Mar 31 | SEC filing · Form 10-Q | — | -3.01% | |
| Form 10-Q Sonnet BioTherapeutics For: Dec 31 | SEC filing · Form 10-Q | -1.27% | +1.27% | |
| Sonnet BioTherapeutics Provides Fiscal Year 2025 First Quarter Business and Earnings Update | Press release | +0.00% | +1.99% | |
| Form 10-K Sonnet BioTherapeutics For: Sep 30 | SEC filing · Form 10-K | -8.25% | -11.34% | |
| Form 10-Q Sonnet BioTherapeutics For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +1.42% | |
| Form 10-Q Sonnet BioTherapeutics For: Mar 31 | SEC filing · Form 10-Q | +3.28% | -2.19% | |
| Sonnet BioTherapeutics Provides Fiscal Year 2024 Second Quarter and Year-to-Date Business and Earnings Update | Press release | +3.28% | -2.19% | |
| Form 10-Q Sonnet BioTherapeutics For: Dec 31 | SEC filing · Form 10-Q | +7.73% | +3.31% | |
| Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update | Press release | +7.73% | +3.31% | |
| Form 10-K Sonnet BioTherapeutics For: Sep 30 | SEC filing · Form 10-K | -1.89% | -11.32% |
Keep exploring
More SONN: analyst actions → · SEC filings → · SONN overview →